– Lirentelimab met histologic co-primary endpoint but missed symptomatic co-primary endpoint – SAN CARLOS, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE)…
NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…
Senhance Surgical System Senhance Surgical System is the first of its kind digital laparoscopic platform providing surgical assurance through haptic…
NEVE ILAN, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging…
Magic mushrooms are set to be analyzed, tested and ready for global distribution this fallVANCOUVER, British Columbia, Sept. 08, 2022…
Five former regulators join Parexel’s Regulatory & Access Consulting team to help customers navigate the complex and evolving global regulatory…
Support, Research, and Saving Lives Remains Focus of First in Person Ovarian Cancer Canada Walk of Hope since 2019 File…
SAN DIEGO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that Henry Ji, Ph.D.,…
Inovalon’s QSI-XL® Cloud Software Solution Empowers More Than 80% of the Nation’s Clinical Outcomes Measurement AnalyticsBOWIE, Md., Sept. 08, 2022…
HAMILTON, Bermuda, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address…